Kyivstar Group Ltd. (KYIV) Q1 2026 Earnings Call Transcript
Kyivstar Group Ltd. (KYIV) Q1 2026 Earnings Call Transcript
seekingalpha.com
INNV(INNV)
INNV
Signal
Bearish Setup2↓
PRICE
Prev Close
7.43
Open
7.38
Day Range7.10 – 7.38
7.10
7.38
52W Range3.13 – 10.69
3.13
10.69
53% of range
VOLUME & SIZE
Avg Volume
306.4K
FUNDAMENTALS
P/E Ratio
-89.0x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.31
Market-like
Performance
1D
-4.17%5D
-11.66%1M
-12.64%3M↓
-14.83%6M
+47.11%YTD
+37.19%1Y↑
+68.72%Best: 1Y (+68.72%)Worst: 3M (-14.83%)
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
revenue +14% YoYValuation
FAIR
P/E not availableHealth
MODERATE
CR 1.0 · FCF $0.29/shBullish
Key MetricsTTM
Market Cap$966.44M
Revenue TTM$945.90M
Net Income TTM-$22.20M
Free Cash Flow$38.87M
Gross Margin20.7%
Net Margin-2.3%
Operating Margin3.9%
Return on Equity-9.2%
Return on Assets-4.1%
Debt / Equity0.41
Current Ratio1.03
EPS TTM$-0.16
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
2 strong3 watch1 concern
46/100Liquidity
1.03Watch
Leverage
0.41Strong
Coverage
8.1xStrong
ROE
-9.2%Concern
ROIC
10.2%Watch
Cash
$64MWatch
ANALYST COVERAGE7 analysts
HOLD
▲ +12.4%upside to target
L $5.00
Med $8.00consensus
H $8.00Stock Health
Composite Score
0 of 5 signals bullish
2/10
Technicals
●
✗RSI RangeRSI 40 — Bearish momentum
Volume
●
✗Volume FlowDistribution — institutional selling
Fundamentals
●
✗Last EarningsMissed estimates
●
~Analyst ConsensusHold
●
~LiquidityCurrent Ratio 1.03
Upcoming Events
EEarnings Report · Before OpenMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentAug 27, 2026
In 103 days
FinancialsFull statements →
Technicals
Technical SetupBEARISH
Technicals →Trend
→ PullbackGolden Cross · 50D leads 200D by 36.8%
-13.1% vs SMA 50 · +18.8% vs SMA 200
Momentum
RSI39.5Momentum fading
MACD-0.18Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$10.69+50.1%
EMA 50
$7.82+9.9%
Current
$7.12
EMA 200
$6.17-13.4%
52W Low
$3.13-56.0%
52-Week RangeMid-range
$3.1353th %ile$10.69
Squeeze SetupVolume-based
Distribution PressureHeavy distribution on elevated volume — institutions appear to be exiting. Squeeze setups unlikely while selling pressure persists.
20-Day Money Flow
Acc days:4
Dist days:3
Edge:+1 acc
Volume Context
Avg Vol (50D)283K
Recent Vol (5D)
350K+24%
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 4 analysts
Analyst revisions:Revenue↑ Revised Up
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2023 | $686.1M $685.1M–$687.1M | — | -$0.26 | — | ±1% | Moderate4 |
FY2024 | $756.2M $755.2M–$757.1M | ▲ +10.2% | -$0.17 | — | ±9% | Moderate3 |
FY2025 | $852.0M $850.5M–$853.5M | ▲ +12.7% | -$0.17 | — | ±1% | Moderate3 |
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryINNV
Last 8Q
-135.5%avg beat
Beat 3 of 8 quartersMissed 5↑ Estimates rising-62%
Q3'24
-5%
Q4'24
-900%
Q1'25
-300%
Q2'25
+50%
Q3'25
+500%
Q4'25
+100%
Q1'26
-467%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced heightAnalyst Activity
All ratings →No recent activity
Goldman SachsNeutral
Dec 28
DOWNGRADE
BarclaysEqual-Weight
Dec 27
DOWNGRADE
Insider Activity
SEC Filings →5 Buys/1 SellNet Buying
Scarbrough Michael …President and …
$162K
Nov 14
SELL
Zoretic Richard CDir
$34K
May 30
BUY
Zoretic Richard CDir
$58K
May 29
BUY
Zoretic Richard CDir
$81K
May 28
BUY
Zoretic Richard CDir
$5K
May 23
BUY
Zoretic Richard CDir
$3K
May 22
BUY
Financials
INSTITUTIONAL OWNERSHIP
1
T. Rowe Price Investment Management, Inc.
6.1M▼2
BlackRock, Inc.
1.2M▼3
Coliseum Capital Management, LLC
1.1M▼4
GEODE CAPITAL MANAGEMENT, LLC
573K▲5
Hillsdale Investment Management Inc.
530K▲6
STATE STREET CORP
431K▲7
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
418K▲8
RENAISSANCE TECHNOLOGIES LLC
371K▲News & Activity
INNV News
20 articles · 4h ago
BlackRock weighs multibillion-dollar investment in SpaceX IPO, the Information reports
reuters.com
Orbit Garant Drilling Q3 Earnings Call Highlights
marketbeat.com
Onex Q1 Earnings Call Highlights
marketbeat.com
Pollard Banknote Q1 Earnings Call Highlights
marketbeat.com
Pet Valu Q1 Earnings Call Highlights
marketbeat.com
Peyto Exploration & Development Q1 Earnings Call Highlights
marketbeat.com
Parex Resources Q1 Earnings Call Highlights
marketbeat.com
Quebecor Q1 Earnings Call Highlights
marketbeat.com
Quarterhill Q1 Earnings Call Highlights
marketbeat.com
Gen Z shoppers helping revive America’s malls with push for in-person experiences
foxbusiness.com
Studies Highlight Advances in Kidney Stone Prevention and Anesthesia Free Stone Removal
globenewswire.com
Kolter Urban Selects FirstService Residential to Manage Art House St. Petersburg
prnewswire.com
KinderCare Learning Companies, Inc. (KLC) Q1 2026 Earnings Call Transcript
seekingalpha.com
Seagate and Western Digital: AI Storage Demand Is Now Showing Up in Pricing Power
247wallst.com
JPMorgan: Locking In A Higher Yield With The Preferred Shares
seekingalpha.com
OpenAI co-founder Greg Brockman reportedly takes charge of product strategy
techcrunch.com
I’ve Been Self-Employed for Seven Years and Finally Made My First Budget: Here’s Why I Cried
247wallst.com
Yanik Guillemette : Le projet de loi C-22 menace l'économie numérique et les investissements technologiques au Québec
globenewswire.com
Yanik Guillemette: Bill C-22 Sparks International Alarm as Tech Giants and VPN Providers Warn Canada Risks Digital Flight
globenewswire.com
About
InnovAge is a market leader in managing the care of high-cost, dual-eligible seniors. Its mission is to enable seniors to age independently in their own homes for as long as possible. Its patient-centered care model meaningfully improves the quality of care its participants receive, while reducing over-utilization of high-cost care settings. InnovAge is at the forefront of value based senior healthcare and directly contracts with government payors, such as Medicare and Medicaid, to manage the totality of a participant’s medical care. InnovAge believes its healthcare model is one in which all constituencies — participants, their families, providers and government payors—“Win.” InnovAge currently serves approximately 6,600 participants across 17 centers in five states.
Peers— Health Care(7 companies)
Screen sector →| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
INNV◀ | $7.12 | -4.17% | $966M | — | +1176.2% | -355.1% | 1500 |
| $66.13 | -5.07% | $13.0B | — | +12626.1% | -14525.8% | 1500 | |
| $94.92 | -3.79% | $12.6B | — | +3288.2% | -4239.0% | 1500 | |
| $523.69 | -3.00% | $12.1B | — | +43205.3% | -3008.0% | 1500 | |
| $227.72 | -1.30% | $11.7B | — | +6554.5% | -2868.8% | 1500 | |
| $57.90 | -0.86% | $11.2B | 50.3 | +1459.3% | 147.7% | 1500 | |
| $76.67 | -3.79% | $10.8B | — | +2325815.3% | -19.7% | 1500 | |
| Sector avg | — | -3.14% | — | 50.3 | +342017.8% | -3552.7% | 1500 |